|
|
 |
|
Viewing report
|
|
|
|
Orthopedics Review and Outlook 2011
UBM Canon, April 2011, Pages: 177
The worldwide orthopedic market generated about $30 billion in sales during 2010. The orthopedic device segment includes products for reconstruction, repairing of fractures, orthobiology, spinal implants, tissue and arthroscopy repair, and others.
Joint reconstruction represents the largest orthopedic implant sector. This category is experiencing high growth each year, especially for gender-specific knee implants along with hip-resurfacing and knee-resurfacing products. The artificial joint market is anticipated to continue driving the orthopedic device market for years to come. Global joint reconstruction is projected to account for almost half of the total orthopedic device market value in 2013.
This special report focuses on the market leaders for orthopedics as well as the products in development anticipated to head this area in the years to come. This compilation’s prescription-product pipeline details the following information for each medicine: chemical or substance composition, intended indication, class of drug, clinical status, region of development, and the product developer/intended marketer. Pipeline status details preclinical development, Phase I, Phase I/II, Phase II, Phase II/III, Phase III, and awaiting approval. Regions of development include the United States, Europe, and Japan. A directory of orthopedic prescription-drug developers and marketers is included.
Additionally provided in this report is a listing of orthopedic medical-device entries, sorted by device class, as well as a directory of medical-device companies associated with the orthopedic field.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
